Microglial Activation and Soluble TREM2 as a Potential Biomarker of Alzheimer’s Disease
Since it was first described in 1906 by Alois Alzheimer, physicians and scientists have been searching for clues to the debilitating neurological condition Alzheimer’s disease (AD). To diagnose and treat the disease at its earliest... Read more













